Both humoral and cell-mediated autoimmune mechanisms have been implicated in the pathogenesis of Guillain-Barre ´syndrome (GBS). Therefore, its occurrence in severely immunocompromised patients is not expected. We identified 3 severely immunocompromised patients who developed GBS. Two of the 3 patie
Guillain-Barré syndrome in Kenya: a clinical review of 54 patients
✍ Scribed by M. Bahemuka
- Publisher
- Springer
- Year
- 1988
- Tongue
- English
- Weight
- 420 KB
- Volume
- 235
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
✦ Synopsis
During an 8-year period, Guillain-Barré syndrome (GBS) was diagnosed in 54 Kenyans. Overall, the outcome was poor. Only 26 patients (48%) walked unaided within 3 month of the height of their paralysis. Five patients (9%) died from respiratory failure and 14 (26%) remained severely disabled from bilateral foot drop by the end of 16 months. Paralysis of lower cranial nerves and sphincter dysfunction were frequently associated with respiratory failure. Whether these features can predict the likelihood of respiratory failure developing requires further evaluation.
📜 SIMILAR VOLUMES
Three patients developed acute Guillain-Barré syndrome while on steroid treatment. The first patient suffered from ulcerative colitis and developed Guillain-Barré syndrome when the steroid dosage was being tapered. Another patient with long-standing multiple sclerosis received steroids during relaps
Guillain-Barre ´syndrome (GBS) is an acute inflammatory polyradiculoneuropathy that usually develops following a respiratory or intestinal infection. Although the pathogenic mechanisms of GBS have not been fully established, both humoral and cell-mediated immune factors have been shown to contribute